Gianfabio Giorgioni

Assistant Professor

University of Camerino

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gianfabio Giorgioni is an Assistant Professor at the University of Camerino, Italy. His research primarily focuses on the pharmacological development of novel compounds for the treatment of glioblastoma and neuropsychiatric disorders. Recent works include investigations into dopamine D4 receptor antagonists and various ligands targeting orexin and ghrelin receptors. He contributes to advancements in medicinal chemistry with an emphasis on selective receptor modulation and the therapeutic potential of copper-based complexes.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (17)

Hideaki Yano

Northeastern University

UNITED STATES

Gianfabio Giorgioni

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma

New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma

Synthesis, Biological, and Computational Evaluations of Conformationally Restricted NAD-Mimics as Discriminant Inhibitors of Human NMN-Adenylyltransferase Isozymes

Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma

Properly Substituted Benzimidazoles as a New Promising Class of Nicotinate Phosphoribosyltransferase (NAPRT) Modulators

Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders

The neuromedin U system: Pharmacological implications for the treatment of obesity and binge eating behavior

Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor Effects

Highly Potent and Selective Dopamine D<sub>4</sub> Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma.

Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor

Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D3 Receptor-Selective or Multitarget Bitopic Ligands Potentially Useful for Central Nervous System Disorders

Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior

Novel Highly Potent and Selective Sigma1 Receptor Antagonists Effectively Block the Binge Eating Episode in Female Rats

Underlying Susceptibility to Eating Disorders and Drug Abuse: Genetic and Pharmacological Aspects of Dopamine D4 Receptors

Collaborators (17)

Hideaki Yano

Loredana CAPPELLACCI

Alessandro Piergentili

Leonardo SORCI

Nadia RAFFAELLI

Wilma Quaglia

Thomas M. Keck

LAURA ZEPPA

Maria Vittoria Micioni Di Bonaventura

Fabio Del Bello

Carlo Cifani

Iole Venditti

Carlo Santini

Alessandro Bonifazi

Maria Giovanna Sabbieti

Riccardo Petrelli

Emanuela Micioni Di Bonaventura

Make your next move.